DCOY 8-K 2026-06-29

Decoy Therapeutics Inc. (DCOY) 8-K dated 2026-06-29 — accession 0001193125-26-286737.

Decoy Therapeutics Inc. (DCOY) common stock.

Decoy Therapeutics Inc. filed a 8-K on 2026-06-29. Accession 0001193125-26-286737.

This 8-K covers: Material agreement (Item 1.01), Unregistered share sale (Item 3.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported DCOY revenue for 2026-06-30 was $227.6K. Net income was -$2.4M.

Not investment advice. The DCOY SEC hub lists recent forms. The stock page is the research view.